COMMUNIQUÉS West-GlobeNewswire

OraSure Technologies, Inc. Announces Two Acquisitions and Reaffirms Fourth Quarter 2018 Guidance
04/01/2019
CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for sample processing, sequencing, and bioinformatics Novosanis’ urine collection technology expands [...]
Vistin Pharma ASA : Trading update for Energy Trading
04/01/2019
Oslo, Norway, 4 January 2019 Reference is made to the announcement yesterday regarding the resignation of Torbjørn Kjus, Head of Energy Trading at Vistin Pharma ASA ("Vistin Pharma" or the "Company"). The Company is in [...]
Zealand Pharma to attend JP Morgan Healthcare Conference and Oddo BHF Forum
04/01/2019
Press release – No. 2 / 2019 Zealand Pharma to attend JP Morgan Healthcare Conference and Oddo BHF Forum Copenhagen, January 4, 2019 – Britt Meelby Jensen, President and Chief Executive Officer of Zealand Pharma, Mats [...]
Evelo Biosciences Announces Dosing of First Patient in Phase 1/2 Clinical Trial of EDP1503 in Combination with KEYTRUDA® (pembrolizumab) in Multiple Oncology Indications
04/01/2019
-- Initial Clinical Data Expected in First Half of 2020 -- CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (NASDAQ:EVLO) (“Evelo”) a biotechnology company developing monoclonal microbials, a [...]
Eckert & Ziegler BEBIG: Meeting Minutes Extraordinary General Meeting
04/01/2019
Seneffe, January 4, 2019. The Minutes and all relevant documents regarding the Extraordinary General Assembly 2018 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About [...]
Eckert & Ziegler BEBIG: Procès verbal de l'assemblée générale extraordinaire des actionnaires
04/01/2019
Seneffe, le 4 janvier 2019. Le procès verbal ainsi que tous les documents relatifs à l'assemblé générale extraordinaire 2018 peuvent être téléchargés sur le site internet: http://www.bebig.com/home/investors/ [...]
Zealand Pharma completes equity investment in strategic partner Beta Bionics
04/01/2019
Press release – No. 1 / 2019 Zealand Pharma completes equity investment in strategic partner Beta Bionics Zealand Pharma invests USD 3.5 million in the final close of strategic partner Beta Bionics’ series B financing [...]
Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients
04/01/2019
Orion Corporation Press release 4 January 2019 at 9.00 a.m. Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients Orion Corporation, a [...]
ASLAN Pharmaceuticals Announces IND Submission for ASLAN003 to U.S. FDA and Conclusion of 30-Day Review Period
04/01/2019
- ASLAN003 is an orally active, potent inhibitor of DHODH that has the potential to be first-in-class in AML - Positive interim Phase 2a data for ASLAN003 in AML was presented at the 2018 ASH Annual Meeting SINGAPORE, [...]
VYZULTA Approved in Canada by Nicox's Partner
04/01/2019
Press Release VYZULTA Approved in Canada by Nicox's Partner ............................................... January 4, 2019 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX [...]
VYZULTA approuvé au Canada par le partenaire licencié de Nicox
04/01/2019
Communiqué de presse VYZULTA TM approuvé au Canada par le partenaire licencié de Nicox ................................................. 4 janvier 2019 - diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext [...]
Basilea presenting at the 37th Annual J. P. Morgan Healthcare Conference - delivering on its strategy
04/01/2019
Basel, Switzerland, January 04, 2019 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that David Veitch, Chief Executive Officer of Basilea, will present at the 37 th Annual J. P. Morgan Healthcare Conference on [...]
Kiadis Pharma expands presence in the United States
04/01/2019
Kiadis Pharma expands presence in the United States Scott Holmes commences position as chief financial officer Amy Sullivan appointed senior vice president, corporate affairs Both are based in Boston, Massachusetts [...]
WishBone Medical’s response to OrthoPediatrics press release
04/01/2019
WARSAW, Ind., Jan. 03, 2019 (GLOBE NEWSWIRE) -- The following is a statement by WishBone Medical: “Both the motion and OrthoPediatrics’ case as a whole are without merit and OP knows it. OP is merely trying to use this [...]
Gritstone Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
EMERYVILLE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]
Avivagen Inc. Announces Change of Auditor
03/01/2019
OTTAWA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) announces the appointment of UHY McGovern Hurley LLP as auditors. UHY McGovern Hurley LLP has been appointed to carry out the audit of [...]
MPX Announces Acquisition of Remaining Interests in Massachusetts Companies
03/01/2019
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC: MPXEF) announced that on December 28, 2018, it had agreed to acquire certain minority interests in two Massachusetts [...]
Leigh Elkolli Promoted to Chief Financial Officer at REVA Medical
03/01/2019
SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced the promotion of Leigh Elkolli to [...]
XOMA Announces Barbara Kosacz Joins its Board of Directors
03/01/2019
EMERYVILLE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today Barbara Kosacz, a Partner at Cooley LLP, has joined the Company’s Board of Directors. Ms. Kosacz is the international [...]

Pages